Erik A. Wist
- Reproductive Medicine top 5%
- Sperm and Testicular Function 2
- Cancer Research top 10%
- Breast Cancer Treatment Studies 7
- Cancer, Lipids, and Metabolism 3
- Oncology top 10%
- Cancer Risks and Factors 6
- Cancer Treatment and Pharmacology 3
-
- Testicular diseases and treatments 2
-
- Childhood Cancer Survivors' Quality of Life 2
-
- Complementary and Alternative Medicine Studies 2
- Co-authors
- Terje RisbergJan NorumSveinung Wergeland SørbyeRoy M. BremnesOlbjørn KleppOlav DahlMarianne BrydøySophie D. Fosså
- Journals
- Journal of Clinical Oncology (2 papers)JNCI Journal of the National Cancer Institute (1 paper)European Urology (1 paper)
- Partner nations
- NorwayUnited StatesGermany
In The Last Decade
Erik A. Wist
18 papers receiving 781 citations
Peers
Comparison fields: 5 of 81
- Reproductive Medicine 144
- Cancer Research 246
- Oncology 398
- Surgery 194
- Pulmonary and Respiratory Medicine 132
Countries citing papers authored by Erik A. Wist
This map shows the geographic impact of Erik A. Wist's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erik A. Wist with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erik A. Wist more than expected).
Fields of papers citing papers by Erik A. Wist
This network shows the impact of papers produced by Erik A. Wist. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erik A. Wist. The network helps show where Erik A. Wist may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Erik A. Wist, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 1 | |
| 2 | 2018 | 66 | |
| 3 | 2017 | 84 | |
| 4 | 2017 | 64 | |
| 5 | 2016 | 29 | |
| 6 | 2015 | 9 | |
| 7 | 2015 | 0 | |
| 8 | 2014 | 10 | |
| 9 | 2014 | 66 | |
| 10 | 2010 | 55 | |
| 11 | 2009 | 11 | |
| 12 | 2005 | 167 | |
| 13 | 2004 | 50 | |
| 14 | 2004 | 20 | |
| 15 | [Should alternative therapists treat cancer--what is the opinion of oncology health personnel?]. | 2003 | 0 |
| 16 | [Does use of alternative medicine aggravate the survival prognosis in cancer?]. | 2003 | 1 |
| 17 | 1997 | 39 | |
| 18 | HOYDOSEBEHANDLING MED AUTOLOG STAMCELLESTOTTE VED MALIGNE LIDELSER | 1996 | 1 |
| 19 | [Attitudes to treatment with cytostatic agents. Do cancer patients, physicians, nurses and healthy individuals vary in their views?]. | 1996 | 1 |
| 20 | Diagnostic delay causes more psychological distress in female than in male cancer patients. | 1996 | 128 |
About Erik A. Wist
Erik A. Wist is a scholar working on Cancer Research, Oncology and Complementary and alternative medicine, having authored 21 papers that have together received 804 indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (7 papers), Cancer Risks and Factors (6 papers), Cancer, Lipids, and Metabolism (3 papers), Cancer Treatment and Pharmacology (3 papers), Testicular diseases and treatments (2 papers), Childhood Cancer Survivors' Quality of Life (2 papers), Complementary and Alternative Medicine Studies (2 papers) and Sperm and Testicular Function (2 papers). The work is most often cited by research in Reproductive Medicine (144 citations), Cancer Research (246 citations) and Oncology (398 citations). Erik A. Wist has collaborated with scholars based in Norway, United States and Germany. Frequent co-authors include Terje Risberg, Jan Norum, Sveinung Wergeland Sørbye, Roy M. Bremnes, Olbjørn Klepp, Olav Dahl, Marianne Brydøy, Sophie D. Fosså, Tore Wentzel‐Larsen and Inger Thune. Their work appears in journals such as Journal of Clinical Oncology, JNCI Journal of the National Cancer Institute and European Urology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.